Canada markets closed

bioAffinity Technologies, Inc. (BIAF)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.2200-0.0400 (-1.77%)
At close: 04:00PM EDT
2.2500 +0.03 (+1.35%)
After hours: 05:31PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
2,532
2,532
4.803
0
0
Cost of Revenue
1,741
1,741
0.467
0
-
Gross Profit
791.615
791.615
4.336
0
-
Operating Expenses
Research Development
1,725
1,725
1,524
1,138
1,610
Selling General and Administrative
6,791
6,791
2,481
1,069
994.343
Total Operating Expenses
8,765
8,765
4,015
2,207
2,604
Operating Income or Loss
-7,973
-7,973
-4,011
-2,207
-2,604
Interest Expense
37.125
37.125
2,533
1,002
382.171
Total Other Income/Expenses Net
-27.796
-27.796
-1,655
-3,116
-4,281
Income Before Tax
-7,916
-7,916
-8,152
-6,324
-7,266
Income Tax Expense
20.993
20.993
2.459
1.95
2.75
Income from Continuing Operations
-7,937
-7,937
-8,154
-6,326
-7,269
Net Income
-7,937
-7,937
-8,154
-6,326
-7,269
Net Income available to common shareholders
-7,937
-7,937
-8,154
-6,326
-7,269
Basic EPS
-0.43
-
-1.81
-2.32
-2.66
Diluted EPS
-0.43
-
-1.81
-2.32
-2.66
Basic Average Shares
8,516
-
4,499
2,728
2,728
Diluted Average Shares
8,516
-
4,499
2,728
2,728